Hims Hers Health

Yahoo Finance • 4 hours ago

Hims & Hers (HIMS) Earnings Call Transcript

Image source: The Motley Fool. DATE Monday, Feb. 23, 2026 at 5 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Andrew DudumChief Financial Officer — Yemi Okupe[Unspecified Role, Moderator] — Bill Newby Need a quote from a Motley F... Full story

Yahoo Finance • 6 hours ago

Earnings live: Hims & Hers stock slides, Domino's rises as investors await crucial update from Nvidia

Fourth quarter earnings season is entering its final stretch. In the week ahead, earnings from Nvidia (NVDA) will mark the final company among the "Magnificent Seven" tech stocks to report quarterly results. This report should offer a cr... Full story

Yahoo Finance • 6 hours ago

Hims & Hers beats on Q4 earnings, shares down in line guidance

Investing.com -- Hims & Hers Health reported fourth-quarter earnings ahead of expectations, though shares were down 2% in Monday aftermarket trading as co issued full-year 2026 revenue guidance largely in line with Wall Street forecasts an... Full story

Yahoo Finance • 6 hours ago

Hims & Hers beats on bottom line in Q4, but Q1 2026 revenue guidance disappoints

[Fourth Quarter Q4 Profits Stock Trading Chart 3D Background] * Although Hims & Hers Health (HIMS [https://seekingalpha.com/symbol/HIMS]) beat [https://seekingalpha.com/news/4555481-hims-and-hers-health-gaap-eps-of-0_08-beats-by-0_03-re... Full story

Yahoo Finance • 6 hours ago

Dow Jones Futures: Trump Tariffs Spark Stock Market Sell-Off; Apple, Nvidia, Tesla Are Key Movers

Dow Jones Futures: The latest Trump tariffs sparked a stock market sell-off Monday. Apple, Nvidia and Tesla were key movers. Continue Reading... Full story

Yahoo Finance • 6 hours ago

Hims & Hers Stock Falls. Why Earnings Are Underwhelming Investors.

Hims & Hers, the telehealth provider best known for its compounded weight-loss drugs, issues a weak outlook. Continue Reading... Full story

Yahoo Finance • 6 hours ago

Hims & Hers forecasts 2026 revenue above estimates

Feb 23 (Reuters) - Hims & Hers Health forecast 2026 revenue above estimates on Monday, ‌betting on increased sales for its ‌personalized healthcare offerings. Shares of the company are down 52% ​so far this year after its plan to launch a... Full story

Yahoo Finance • 6 hours ago

Hims & Hers Health GAAP EPS of $0.08 beats by $0.03, revenue of $617.82M in-line

* Hims & Hers Health press release [https://seekingalpha.com/pr/20409702-hims-and-hers-health-inc-reports-fourth-quarter-and-full-year-2025-financial-results] (HIMS [https://seekingalpha.com/symbol/HIMS]): Q4 GAAP EPS of $0.08 beats by $... Full story

Yahoo Finance • 5 days ago

Hims & Hers Agrees To Buy Eucalyptus In $1.15 Bil Deal. Stock Rallies.

Him stock rose after the telehealth company announced that it had agreed to acquire Eucalyptus in a $1.15 billion deal. Continue Reading... Full story

Yahoo Finance • 5 days ago

Hims & Hers to Buy Australian Telehealth Provider Eucalyptus in $1.15 Billion Deal

Hims & Hers Health will buy Eucalyptus, an Australian digital health company, in a deal valued at $1.15 billion. Continue Reading... Full story

Yahoo Finance • 5 days ago

Stocks making the biggest moves premarket: Walmart, Hims & Hers, Carvana, Figma & more

Check out the companies making the biggest moves in premarket trading: Walmart — The big-box retailer shed 3.7% after its full fiscal year outlook fell short of expectations. Walmart said it anticipates net sales will increase by 3.5% to 4... Full story

Yahoo Finance • 5 days ago

Hims & Hers Q4 Earnings Preview: What To Expect From Upcoming Report

This article first appeared on GuruFocus. Hims & Hers (HIMS) is set to report fourth-quarter fiscal 2025 results after market close on Feb. 23. Analysts expect earnings to decline, while revenue may see a moderate rise. The telehealth co... Full story

Yahoo Finance • 5 days ago

Analysis-Hims & Hers GLP-1 pill gambit backfires, accelerating crackdown on drug compounders

By Michael Erman NEW YORK, Feb 19 (Reuters) - Online telehealth company Hims & Hers Health, seeking growth drivers as its original sexual-health franchises matured, may have overstepped with a risky launch of weight-loss pills that drew s... Full story

Yahoo Finance • 6 days ago

Deutsche Bank Cite Near-Term Growth Concerns For Hims & Hers Health, Inc. (HIMS) Following GLP-1 Launch Reversal

Hims & Hers Health, Inc. (NYSE:HIMS) is among the 15 Innovative Healthcare Stocks to Buy According to Analysts.Deutsche Bank Cite Near-Term Growth Concerns For Hims & Hers Health, Inc. (HIMS) Following GLP-1 Launch Reversal Hims & Hers He... Full story

Yahoo Finance • 6 days ago

Hims & Hers Faces New Hurdle In Weight-Loss Brawl With Novo Nordisk

Hims stock landed in hot water this month after Novo Nordisk slammed the telehealth giant with a lawsuit over its knockoff obesity drug. Continue Reading... Full story

Yahoo Finance • 7 days ago

Novo Nordisk Patent Fight With Hims And Hers Puts Valuation In Focus

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Novo Nordisk has filed a lawsuit against Hims & Hers Health accusing it of infringing patents re... Full story

Yahoo Finance • 10 days ago

Novo Nordisk Faces Dual FDA Scrutiny And Legal Fights Over Obesity Drugs

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Novo Nordisk (NYSE:NVO) is pursuing legal and regulatory action against Hims & Hers and other comp... Full story

Yahoo Finance • 10 days ago

Hims & Hers Falls Over 50% as Novo Files Obesity Lawsuit

This article first appeared on GuruFocus. Short sellers are pressing their advantage in Hims & Hers Health (NYSE:HIMS) as legal overhang reshapes the narrative around its weight-loss push. The shares have fallen more than 50% this year th... Full story

Yahoo Finance • 10 days ago

Hims & Hers short interest climbs amid legal risk related to weight loss pill

[Closeup of computer keyboard with short and long buttons. Stock market, Trading concept.] Sashkinw Short interest in Hims & Hers Health (HIMS [https://seekingalpha.com/symbol/HIMS]) has spiked as shares of the telehealth platform plunged... Full story

Yahoo Finance • 11 days ago

Hedge funds bet big against Hims & Hers Health before Wegovy showdown, Hazeltree data shows

By Nell Mackenzie and Samuel Indyk LONDON, Feb 13 (Reuters) - Hedge fund bets against Hims & Hers Health hit their highest in at ‌least a year in January, just before the online telehealth ‌firm clashed with Novo Nordisk over its cut-pric... Full story